$0.90-0.08 (-7.97%)
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. in the Healthcare sector is trading at $0.90 with a market capitalization of $90M. Wall Street consensus targets $5.13 (3 analysts), implying a +472.8% move over the next 12 months. The stock is currently near its 52-week low of $0.73, remaining 64.9% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 17 is oversold, raising the odds of a near-term bounce. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.31M↑ | $3.72M↑ | $3.45M↑ | $3.04M↑ | $2.81M |
| Gross Profit | -$2.59M↑ | -$3.62M↓ | -$2.88M↑ | -$3.24M↓ | -$3.05M |
| Operating Income | -$14.53M↑ | -$17.88M↓ | -$14.23M↑ | -$14.49M↓ | -$14.09M |
| Net Income | -$14.27M↑ | -$33.37M↓ | -$13.68M↑ | -$14.72M↓ | -$13.24M |
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The co...
Nano X Imaging Ltd (NNOX) reports increased revenues and strategic partnerships, but faces cash flow concerns and revised revenue targets.
Moby summary of Nano-X Imaging Ltd.'s Q1 2026 earnings call
BlackBerry also ranks highly before upcoming report
Need a quote from a Motley Fool analyst? Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities, regulatory process and clinical activities, among other matters.
Nano-X Imaging Ltd. (NASDAQ:NNOX) earns a place on our list of the most popular AI penny stocks to buy. With distribution partnerships and deployment agreements beginning to translate into measurable commercial traction, Nano-X Imaging Ltd. (NASDAQ:NNOX) appears to be marking its entry into a scaled, partner-driven rollout phase. Nanox Impact Inc., the company’s subsidiary, penned […]